Trial intelligence / Profile preview

Local Pilocarpine for Dry Mouth in Elderly

NCT04195100Phase 1Completed

Sponsor
Maastricht University Medical Center+
Start
Apr 2019
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of pilocarpine in xerostomia (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Change in xerostomia score (Numeric Rating Scale) at 3 weeks and Change in oral health-related quality of life (Dutch Geriatric Oral Health Assessment Index) at 2 weeks. Started Apr 2019; status: completed.

02

Drugs

pilocarpine
03

Conditions

xerostomia

Beyond the preview

Go deeper on NCT04195100.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04195100.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call